Overview
Ying Cheng practices practicing medicine in Changchun, China.
Ms. Cheng is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Tissue Biopsy, and Gastrectomy.
She is actively involved in clinical research, co-authoring 359 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ying J. Cheng
Is Ying J. Cheng a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Ying J. Cheng is classified as an Distinguished expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ying J. Cheng participate in research or clinical trials?
Yes. Ying J. Cheng has published 359 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Ying J. Cheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerMs. Cheng isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerMs. Cheng isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung CancerMs. Cheng isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Cheng isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Ms. Cheng isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- AgranulocytosisMs. Cheng isAdvanced. Learn about Agranulocytosis.
- HypertensionMs. Cheng isAdvanced. Learn about Hypertension.
- Lung MetastasesMs. Cheng isAdvanced. Learn about Lung Metastases.
- ParonychiaMs. Cheng isAdvanced. Learn about Paronychia.
- Vascular RingMs. Cheng isAdvanced. Learn about Vascular Ring.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Cheng isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaMs. Cheng isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Adult T-Cell LeukemiaMs. Cheng isExperienced. Learn about Adult T-Cell Leukemia.
- Anal CancerMs. Cheng isExperienced. Learn about Anal Cancer.
- AngiosarcomaMs. Cheng isExperienced. Learn about Angiosarcoma.
- Bone TumorMs. Cheng isExperienced. Learn about Bone Tumor.